Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Mouse Anti-Influenza A, Matrix Protein-UNLB (FluAc)

Cat. No.:
Purified Anti-Influenza A, Matrix Protein antibody for use in immunocytochemistry, ELISA, and western blot assays.
Size Price (USD) Quantity
0.1 mg $160.00
More Information
Clone FluAc
Isotype Mouse (BALB/c) IgG2bκ
Isotype Control Mouse IgG2b-UNLB (A-1)
Specificity Influenza virus type A matrix protein
Alternative Names M1
Description Influenza virus type A matrix protein, also known as M1, is composed of a 252 amino acid sequence and is type-specific in influenza viruses. It is located inside the viral lipid envelope and plays a key role in virus assembly and replication. M1 can be isolated from particles by removing the envelope with detergents and reducing the pH to 4.0. The monoclonal antibody FluAc has been shown to specifically recognize type A influenza virus M1 in virus infected cell culture.
Immunogen Recombinant influenza virus type A matrix protein
Conjugate UNLB (Unconjugated)
Buffer Formulation Borate buffered saline, pH 8.2
Clonality Monoclonal
Concentration 0.5 mg/mL
Volume 0.2 mL
Recommended Storage 2-8°C
Applications ELISA – Quality tested
Immunocytochemistry 4
Western Blot – Reported in literature 1-3

RRID Number AB_2794438

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?
or call 800.722.2255
  1. 1. Hamamoto I, Harazaki K, Inase N, Takaku H, Tashiro M, Yamamoto N. Cyclosporin A inhibits the propagation of influenza virus by interfering with a late event in the virus life cycle. Jpn J Infect Dis. 2013;66:276-83. (WB)
  2. 2. Tripathi S, Batra J, Cao W, Sharma K, Patel JR, Ranjan P, et al. Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin. Cell Death Dis. 2013;4:e562. (WB)
  3. 3. Yang C, Skiena S, Futcher B, Mueller S, Wimmer E. Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice. Proc Natl Acad Sci USA. 2013;110:9481-6. (WB)
  4. 4. SouthernBiotech published data (ICC)
See All References